直覺外科公司 ISRG 深 滬
已收盤 02-06 16:00:00 美东时间
488.15
+11.830
+2.48%
華盛通- 最 高491.65
- 今 開482.165
- 成交量 252.11万股
- 最 低 480.07
- 昨 收 476.32
- 總市值 1733.57亿
- 52周最高 609.08
- 市盈率 靜 61.99
- 換手率 0.71%
- 52周最低 425.00
- 委 比 84.70%
- 總股本 3.55亿
- 歷史最高 616.00
- 量 比 0.90
- 振 幅 2.43%
- 歷史最低 35.5555
- 每 手 1
- 風險率 45.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Officer Patricia L. Wadors
Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Officer Patricia L. Wadors Intuitive Surgical Inc. has filed an initial statement of beneficial ownership (Form 3) with the SEC. The filing identifies Patricia L. Wadors as the beneficial owner in her role as an officer of t
02-06 05:54
财报速睇 | 直觉外科公司 2025财年年度营收100.65亿美元，同比增长20.5%；归母净利润28.56亿美元，同比增长22.9%
华盛资讯2月4日讯，直觉外科公司公布2025财年年度业绩，公司年度营收100.65亿美元，同比增长20.5%，归母净利润28.56亿美元，同比增长22.9%。
02-04 22:21
U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico
U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico Feb 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ametek, Coca-Cola and Pepsico, on Wednesday. HIGHLIGHTS * Ametek AME.N : RBC raises target price to $257 from $229 *
02-04 14:59
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings
U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings Jan 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AMETEK, Stryker and Zimmer Biomet Holdings, on Tuesday. HIGHLIGHTS * AMETEK AME.N : Oppenheimer cuts to
01-27 15:49
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
FDA Clears Intuitive Surgical's Da Vinci 5 System for Cardiac Procedures
FDA Clears Intuitive Surgical's Da Vinci 5 System for Cardiac Procedures Intuitive Surgical Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its da Vinci 5 system to be used in certain cardiac procedures. The approved indications include mitral valve repair, internal ma
01-26 22:15
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
Da Vinci 5 Cleared for Cardiac Procedures
Intuitive announced FDA clearance for the da Vinci 5 system to perform certain cardiac procedures, including mitral valve repair and IMA mobilization. Cardiovascular disease remains a leading cause of death globally, with millions undergoing open-heart surgery annually. The da Vinci 5 enables minimally invasive approaches, reducing pain and recovery time. It offers advanced features like 10,000x computing power, smart instrumentation, and enhance...
01-26 14:15
